Patents-Review.com
ClassID:

94843 ⎘

C07D291/08 - CPC Classification

Classification description:

Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Recent Application in this class:
#1
20250289793
2025-09-18

MACROCYCLIC INHIBITORS OF ATP CITRATE LYASE

 #2
20240132459
2024-04-25

PROCESS AND INTERMEDIATES FOR THE PREPARATION OF CERTAIN NEMATICIDAL SULFONAMIDES

 #3
20230024995
2023-01-26

NRF2-ACTIVATING COMPOUND

 #4
20220363651
2022-11-17

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #5
20220315548
2022-10-06

SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF

 #6
20220242839
2022-08-04

Process and intermediates for the preparation of certain nematicidal sulfonamides

 #7
20220204461
2022-06-30

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #8
20220020934
2022-01-20

5,6-DIPHENYL-5,6-DIHYDRO-DIBENZ[C,E][1,2]AZAPHOSPHORIN AND 6-PHENYL-6H-DIBENZO[C,E][1,2]THIAZIN-5,5-DIOXIDE DERIVATIVES AND SIMILAR COMPOUNDS AS ORGANIC ELECTROLUMINESCENT MATERIALS FOR OLEDS

 #9
20210309621
2021-10-07

Process and intermediates for the preparation of certain nematicidal sulfonamides

 #10
20210179635
2021-06-17

CYCLIZED SULFAMOYLARYLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

 #11
20210009540
2021-01-14

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #12
20210009539
2021-01-14

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #13
20210009538
2021-01-14

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #14
20200262939
2020-08-20

Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit

 #15
20200262802
2020-08-20

Photo-crosslinked hydrogel material and preparation, composition, and application thereof photo-crosslinked hydrogel

 #16
20200062781
2020-02-27

Bisaryl heterocycles as NRF2 activators

 #17
20200055830
2020-02-20

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #18
20200048212
2020-02-13

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #19
20200048211
2020-02-13

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #20
20200002298
2020-01-02

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #21
20190127339
2019-05-02

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #22
20190119235
2019-04-25

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #23
20190119234
2019-04-25

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #24
20190119233
2019-04-25

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #25
20190119232
2019-04-25

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #26
20190119231
2019-04-25

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #27
20190119230
2019-04-25

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #28
20190119229
2019-04-25

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #29
20190119228
2019-04-25

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #30
20190119227
2019-04-25

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #31
20190112284
2019-04-18

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #32
20190112283
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #33
20190112282
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #34
20190112281
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #35
20190112280
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #36
20190112279
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #37
20190062288
2019-02-28

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #38
20190016693
2019-01-17

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #39
20190016692
2019-01-17

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #40
20190002454
2019-01-03

NRF2 Regulators

 #41
20180362543
2018-12-20

HIV REPLICATION INHIBITOR

 #42
20180230112
2018-08-16

Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols

 #43
20180230102
2018-08-16

Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof

 #44
20180022719
2018-01-25

Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors

 #45
20170002025
2017-01-05

Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

 #46
20160347744
2016-12-01

Fused heterocyclic compounds as ion channel modulators

 #47
20160318917
2016-11-03

Nrf2 regulators

 #48
20160222028
2016-08-04

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #49
20160222026
2016-08-04

Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors

 #50
20160222022
2016-08-04

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #51
20160221973
2016-08-04

3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #52
20160221972
2016-08-04

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #53
20160096846
2016-04-07

Fused heterocyclic compounds as ion channel modulators

 #54
20150051183
2015-02-19

Conformationally constrained, fully synthetic macrocyclic compounds

 #55
20150030539
2015-01-29

Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors

 #56
20140135317
2014-05-15

Fused heterocyclic compounds as ion channel modulators

 #57
20140024584
2014-01-23

Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof

 #58
20140011988
2014-01-09

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

 #59
20130345128
2013-12-26

Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof

 #60
20130345126
2013-12-26

Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof

 #61
20130345125
2013-12-26

Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof

 #62
20130338066
2013-12-19

Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof

 #63
20130012492
2013-01-10

Fused heterocyclic compounds as ion channel modulators

 #64
20120208859
2012-08-16

MEK inhibitors useful in the treatment of diseases

 #65
20120157658
2012-06-21

METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS

 #66
20120094983
2012-04-19

Acyclic Iinhibitors

 #67
20120071462
2012-03-22

Dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them

 #68
20110196147
2011-08-11

INHIBITORS OF HISTONE DEACETYLASE

 #69
20110118240
2011-05-19

4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides

 #70
20100267703
2010-10-21

4-amino-1,2,3-benzoxathiazine-derivatives as pesticides

 #71
20100233086
2010-09-16

COMPOUNDS FOR USE IN IMAGING, DIAGNOSING AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS

 #72
20100216970
2010-08-26

Methods, compositions, and apparatuses for forming macrocyclic compounds

 #73
20090191129
2009-07-30

Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors

 #74
20080275023
2008-11-06

N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations

 #75
20080214526
2008-09-04

Macrocyclic compounds and compositions useful as BACE inhibitors

 #76
20080207590
2008-08-28

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

 #77
20080171737
2008-07-17

CYCLIC SULFONAMIDE DERIVATIVES AND METHODS OF THEIR USE

 #78
20080070885
2008-03-20

MACROCYCLIC COMPOUNDS HAVING ASPARTIC PROTEASE INHIBITING ACTIVITY AND PHARMACEUTICAL USES THEREOF

 #79
20070293682
2007-12-20

Methods of Preparing Sulfinamides and Sulfoxides

 #80
20070217965
2007-09-20

Methods, compositions, and apparatuses for forming macrocyclic compounds

 #81
20070082909
2007-04-12

Acyclic Iinhibitors

 #82
20060223745
2006-10-05

Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof

 #83
20060128767
2006-06-15

Methods of preparing sulfinamides and sulfoxides

 #84
20050043373
2005-02-24

Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom